Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma-Reference-Cited by-同舟云学术

Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma

Published:2018-01-16 Issue:5 Volume:96 Page:503-509
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Djirackor Luna¹^ORCID,Shakir Dilem¹,Kalirai Helen¹,Petrovski Goran²³,Coupland Sarah E.¹

Affiliation:

1. Department of Molecular and Clinical Cancer Medicine; Institute of Translational Medicine; University of Liverpool; Liverpool UK

2. Stem Cells and Eye Research Laboratory; Department of Ophthalmology; Faculty of Medicine; Albert Szent-Gyorgyi Clinical Center; University of Szeged; Szeged Hungary

3. Centre for Eye Research; Department of Ophthalmology; Oslo University Hospital and University of Oslo; Oslo Norway

Funder

Eye Tumour Research Fund, Charitable Funds, Royal Liverpool University Hospital NHS Trust

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aos.13645/fullpdf

Reference33 articles.

1. Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma;Akiyama;J Invest Dermatol,2013

2. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc Natl Acad Sci USA,2003

3. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker;Barak;Invest Ophthalmol Vis Sci,2007

4. Nestin expression in cutaneous melanomas and melanocytic nevi;Brychtova;J Cutan Pathol,2007

5. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis;Chang;Melanoma Res,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis;Frontiers in Oncology;2022-10-20

2. Recent advances in understanding the role of HES6 in cancers;Theranostics;2022

3. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions;Cancers;2021-12-25

4. Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology;Progress in Retinal and Eye Research;2021-11

5. Novel Prognostic Immunohistochemical Markers in Uveal Melanoma-Literature Review;Cancers;2021-08-10